✦ LIBER ✦

Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study

✍ Scribed by B. M. Ewenstein; E. D. Gomperts; S. Pearson; M. E. O'Banion

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective surveillance study of fact

✍ M. RUBINGER; D. LILLICRAP; G. E. RIVARD; J. TEITEL; M. CARCAO; C. HENSMAN; I. WA 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Efficacy and inhibitor development in pr

✍ Alessandro Gringeri; Annarita Tagliaferri; Giuseppe Tagariello; Massimo Morfini; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Rate of inhibitor development in previou

✍ A. IORIO; S. HALIMEH; S. HOLZHAUER; N. GOLDENBERG; E. MARCHESINI; M. MARCUCCI; G 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Efficacy and inhibitor development in pr

✍ Peter Larson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Prior and concurrent administration of r

✍ K. Geissler; J.A. Liu Yin; A. Ganser; M.A. Sanz; J. Szer; A. Raghavachar; D. Hoe 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 218 KB